Avalo Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2017

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Avalo Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2017.
  • Avalo Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -7.68K %, a 505% decline year-over-year.
  • Avalo Therapeutics, Inc. annual Operating Margin for 2017 was 49.9 %.
Operating Margin, Annual (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.